系统免疫炎症指数与急性冠脉综合征患者PCI术后冠状动脉病变进展的相关性研究
Correlation Analysis of SII with Progression of Coronary Lesions in Patients with Acute Coronary Syndrome after PCI
摘要: 目的:探究系统免疫炎性指数(SII)与急性冠状动脉综合征经皮冠脉介入治疗(PCI)术后病变血管进展的相关性。方法:回顾性分析2019年1月至2022年6月于安徽医科大学第二附属医院初次行PCI治疗并在6~24个月内再次行冠脉造影术(CAG)复查的194例急性冠脉综合征患者,其中100例发生了病变血管进展(进展组),94例未发生病变血管进展(非进展组)。通过入院后检测患者血小板、中性粒细胞及淋巴细胞水平,计算患者基线期及随访期SII水平,比较两组患者的临床资料;评估SII对患者预后的预测价值。结果:进展组吸烟患者的占比、CRP数值高于非进展组(P < 0.05);非进展组SII、PLR、NLR及NHR均低于进展组(P < 0.05);SII、PLR、NLR及NHR升高是急性冠状动脉综合征患者PCI术后病变血管进展的独立危险因素(P < 0.05);SII预测急性冠状动脉综合征患者PCI术后病变血管进展的价值最高,约登指数最大时,曲线下面积(AUC)为0.745,对应临界值为8.570,特异度和敏感度分别为73.00%和78.30%。结论:SII、PLR、NLR及NHR对急性冠状动脉综合征PCI术后病变血管进展具有良好的预测价值,其中SII更具有诊断预测价值,为患者临床治疗提供一定指导作用。
Abstract: Objective: To explore the correlation between the Systemic Immune-Inflammation Index (SII) and the rapid progression of lesion vessels after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome. Methods: A retrospective analysis was conducted on 194 patients with acute coronary syndrome who underwent their first PCI treatment at the Second Affiliated Hospital of Anhui Medical University from January 2019 to June 2022 and underwent CAG re-examination within 6 to 24 months. Among them, 100 cases experienced rapid progression of lesion vessels (progression group), and 94 cases showed no progression (non-progression group). By measuring the levels of platelets, neutrophils, and lymphocytes in patients after admission, the SII levels at baseline and follow-up periods were calculated, and the clinical data of the two groups of patients were compared; the predictive value of SII for patient prognosis was assessed. Results: The proportion of smokers and CRP values in the progression group were higher than those in the non-progression group (P < 0.05); the SII, PLR, NLR, and NHR in the non-progression group were all lower than those in the progression group (P < 0.05); increased SII, PLR, NLR, and NHR are independent risk factors for the rapid progression of lesion vessels after PCI in patients with acute coronary syndrome (P < 0.05); SII has the highest predictive value for the rapid progression of lesion vessels after PCI in patients with acute coronary syndrome, with the area under the curve (AUC) being 0.745 when the Youden index is the largest, corresponding to a critical value of 8.570, with specificity and sensitivity of 73.00% and 78.30%, respectively. Conclusion: SII, PLR, NLR, and NHR have good predictive value for the rapid progression of lesion vessels after PCI in patients with acute coronary syndrome, among which SII has a higher diagnostic predictive value and provides certain guidance for clinical treatment of patients.
文章引用:刘昕, 麻昌伟, 盛建龙. 系统免疫炎症指数与急性冠脉综合征患者PCI术后冠状动脉病变进展的相关性研究 [J]. 临床医学进展, 2025, 15(5): 840-852. https://doi.org/10.12677/acm.2025.1551442

参考文献

[1] 刘明波, 何新叶, 杨晓红, 等.《中国心血管健康与疾病报告2023》概要(心血管疾病流行及介入诊疗状况) [J]. 中国介入心脏病学杂志, 2024, 32(10): 541-550.
[2] Ibánez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, C., Bueno, H., et al. (2017) 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. Revista Española de Cardiología (English Edition), 70, Article 1082. [Google Scholar] [CrossRef] [PubMed]
[3] Hannan, E.L., Wu, C., Walford, G., Culliford, A.T., Gold, J.P., Smith, C.R., et al. (2008) Drug-Eluting Stents Vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease. New England Journal of Medicine, 358, 331-341. [Google Scholar] [CrossRef] [PubMed]
[4] Tousek, P., Pavei, A., Oreglia, J., Martin, G., Sharif, F., Fajadet, J., et al. (2009) Impact of Atherosclerotic Disease Progression on Mid-Term Clinical Outcome in Diabetic Patients in the Drug-Eluting Stent Era. EuroIntervention, 4, 588-592.
[5] Montecucco, F., Liberale, L., Bonaventura, A., Vecchiè, A., Dallegri, F. and Carbone, F. (2017) The Role of Inflammation in Cardiovascular Outcome. Current Atherosclerosis Reports, 19, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[6] Sari, I., Sunbul, M., Mammadov, C., Durmus, E., Bozbay, M., Kivrak, T., et al. (2015) Relation of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio with Coronary Artery Disease Severity in Patients Undergoing Coronary Angiography. Kardiologia Polska, 73, 1310-1316. [Google Scholar] [CrossRef] [PubMed]
[7] Wada, H., Dohi, T., Miyauchi, K., Shitara, J., Endo, H., Doi, S., et al. (2017) Pre-Procedural Neutrophil-to-Lymphocyte Ratio and Long-Term Cardiac Outcomes after Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Atherosclerosis, 265, 35-40. [Google Scholar] [CrossRef] [PubMed]
[8] Ugur, M., Gul, M., Bozbay, M., Cicek, G., Uyarel, H., Koroglu, B., et al. (2014) The Relationship between Platelet to Lymphocyte Ratio and the Clinical Outcomes in ST Elevation Myocardial Infarction Underwent Primary Coronary Intervention. Blood Coagulation & Fibrinolysis, 25, 806-811. [Google Scholar] [CrossRef] [PubMed]
[9] Duffy, B.K., Gurm, H.S., Rajagopal, V., Gupta, R., Ellis, S.G. and Bhatt, D.L. (2006) Usefulness of an Elevated Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality after Percutaneous Coronary Intervention. The American Journal of Cardiology, 97, 993-996. [Google Scholar] [CrossRef] [PubMed]
[10] Davì, G. and Patrono, C. (2007) Platelet Activation and Atherothrombosis. New England Journal of Medicine, 357, 2482-2494. [Google Scholar] [CrossRef] [PubMed]
[11] Hu, B., Yang, X., Xu, Y., Sun, Y., Sun, C., Guo, W., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef] [PubMed]
[12] 刘圣均, 权薇薇, 张瑞岩. 冠心病患者冠状动脉支架植入术后糖代谢异常对非靶病变进展的影响[J]. 介入放射学杂志, 2020, 29(8): 758-762.
[13] 国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南(第2版) [J]. 中国医学前沿杂志(电子版), 2018, 10(6): 1-130.
[14] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[15] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
[16] 董亚兰, 胡德胜. 动脉粥样硬化的炎症应答特征及运用[J]. 中国动脉硬化杂志, 2022, 30(4): 304-312.
[17] Hedrick, C.C. (2015) Lymphocytes in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 253-257. [Google Scholar] [CrossRef] [PubMed]
[18] 沐露霞, 汪斌, 孙震. 中性粒细胞/高密度脂蛋白比值与老年高血压患者合并冠心病的相关性[J]. 中国老年学杂志, 2023, 43(16): 3852-3854.
[19] Jiang, M., Sun, J., Zou, H., Li, M., Su, Z., Sun, W., et al. (2022) Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population. Frontiers in Cardiovascular Medicine, 9, Article 807339. [Google Scholar] [CrossRef] [PubMed]
[20] Guo, J., Chen, M., Hong, Y., Huang, Y., Zhang, H., Zhou, Y., et al. (2023) Comparison of the Predicting Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Monocyte to High-Density Lipoprotein Cholesterol Ratio for In-Hospital Prognosis and Severe Coronary Artery Stenosis in Patients with ST-Segment Elevation Acute Myocardial Infarction Following Percutaneous Coronary Intervention: A Retrospective Study. Journal of Inflammation Research, 16, 4541-4557. [Google Scholar] [CrossRef] [PubMed]
[21] Li, C., Shen, Y., Xu, R., Dai, Y., Chang, S., Lu, H., et al. (2018) Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions. Angiology, 70, 272-278. [Google Scholar] [CrossRef] [PubMed]
[22] Li, X., Fang, H., Li, D., Xu, F., Yang, B., Zhang, R., et al. (2020) Association of Platelet to Lymphocyte Ratio with In-Hospital Major Adverse Cardiovascular Events and the Severity of Coronary Artery Disease Assessed by the Gensini Score in Patients with Acute Myocardial Infarction. Chinese Medical Journal, 133, 415-423. [Google Scholar] [CrossRef] [PubMed]
[23] Li, Q., Ma, X., Shao, Q., Yang, Z., Wang, Y., Gao, F., et al. (2022) Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Frontiers in Cardiovascular Medicine, 9, Article 811790. [Google Scholar] [CrossRef] [PubMed]
[24] Han, K., Shi, D., Yang, L., Wang, Z., Li, Y., Gao, F., et al. (2022) Prognostic Value of Systemic Inflammatory Response Index in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Annals of Medicine, 54, 1667-1677. [Google Scholar] [CrossRef] [PubMed]
[25] Candemir, M., Kiziltunç, E., Nurkoç, S. and Şahinarslan, A. (2021) Relationship between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology, 72, 575-581. [Google Scholar] [CrossRef] [PubMed]
[26] Mitsis, A., Kyriakou, M., Sokratous, S., Karmioti, G., Drakomathioulakis, M., Myrianthefs, M., et al. (2024) Exploring the Landscape of Anti-Inflammatory Trials: A Comprehensive Review of Strategies for Targeting Inflammation in Acute Myocardial Infraction. Biomedicines, 12, Article 701. [Google Scholar] [CrossRef] [PubMed]
[27] Bulnes, J.F., González, L., Velásquez, L., Orellana, M.P., Venturelli, P.M. and Martínez, G. (2024) Role of Inflammation and Evidence for the Use of Colchicine in Patients with Acute Coronary Syndrome. Frontiers in Cardiovascular Medicine, 11, Article 1356023. [Google Scholar] [CrossRef] [PubMed]